OVERVIEW
Solving complex drug development challenges together
At Etcembly, partnerships begin with a problem. Whether it’s a novel biological question or a unique development hurdle, we collaborate closely to help your team explore more ideas, test them faster, and build better therapeutics at the speed of imagination.
THE OPPORTUNITY
Why partner with Etcembly
Custom solutions
Every partnership is built around a specific scientific or strategic need. We don’t apply generic tools to complex problems. We design tailored solutions grounded in your unique challenges and objectives.
AI+drug development expertise
Our team operates at the intersection of computational innovation and translational science. That dual perspective allows us to deliver solutions that are not only technically sophisticated but biologically meaningful.
Collaborative by design
Our partnerships are built on responsiveness and shared ambition. We work closely with you to align on goals, define success metrics, and iterate rapidly.
PARTNERSHIP HIGHLIGHTS
This collaboration combined Etcembly’s AI-driven antibody optimisation capabilities with Zelluna’s pioneering work in cell therapy to support the development of ZI-MA4-1, a T-cell receptor natural killer (TCR-NK) therapy targeting solid tumours. ZI-MA4-1
Explore the progress of ZI-MA4-1 toward first-in-human trials →
